Formulation and Evaluation of Nitrendipine Buccal Films
2008
Nitrendipine Buccal Films
publication
Evidence: moderate
Author Information
Author(s): Nappinnai M., Chandanbala R., Balaijirajan R.
Primary Institution: C. L. Baid Mehta College of Pharmacy
Hypothesis
Buccal delivery of nitrendipine may circumvent hepatic first pass metabolism to improve its bioavailability.
Conclusion
The best formulation for buccal delivery of nitrendipine was found to be F-4, which showed moderate drug release and satisfactory film characteristics.
Supporting Evidence
- The buccal route offers advantages like avoiding first pass metabolism and controlled drug delivery.
- Nitrendipine has low oral bioavailability and extensive hepatic metabolism.
- Formulation F-4 showed moderate drug release of 50% at the end of 2 hours.
Takeaway
The study created a special film to deliver a medicine called nitrendipine through the mouth, which can help the body use the medicine better.
Methodology
The study involved formulating mucoadhesive buccal films using various polymers and evaluating their physicochemical properties and drug release characteristics.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website